BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC)
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate if BAY43-9006 has an effect on the tumors, how long
the effect continues, if the patients receiving BAY43-9006 will live longer.
- If BAY43-9006 has an effect on the quality of life of patients with non-small cell lung
cancer.
- If BAY43-9006 helps to slow the worsening of non-small cell lung cancer.
- If BAY43-9006 prevents the growth of, or shrinks non-small cell lung tumors and/or their
metastases.